Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 8 May 1981:
Vol. 212. no. 4495, pp. 628 - 635
DOI: 10.1126/science.6261329
Prev | Table of Contents | Next

Articles

Science, Vol 212, Issue 4495, 628-635
Copyright © 1981 by American Association for the Advancement of Science

articles

Regulation of plasma cholesterol by lipoprotein receptors

MS Brown, PT Kovanen, and JL Goldstein

The lipoprotein transport system holds the key to understanding the mechanisms by which genes, diet, and hormones interact to regulate the plasma cholesterol level in man. Crucial components of this system are lipoprotein receptors in the liver and extrahepatic tissues that mediate the uptake and degradation of cholesterol-carrying lipoproteins. The number of lipoprotein receptors, and hence the efficiency of disposal of plasma cholesterol, can be increased by cholesterol-lowering drugs. Regulation of lipoprotein receptors can be exploited pharmacologically in the therapy of hypercholesterolemia and atherosclerosis is man.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
The Epidermal Growth Factor Homology Domain of the LDL Receptor Drives Lipoprotein Release through an Allosteric Mechanism Involving H190, H562, and H586.
Z. Zhao and P. Michaely (2008)
J. Biol. Chem. 283, 26528-26537
   Abstract »    Full Text »    PDF »
Hormone-sensitive lipase is involved in hepatic cholesteryl ester hydrolysis.
M. Sekiya, J.-i. Osuga, N. Yahagi, H. Okazaki, Y. Tamura, M. Igarashi, S. Takase, K. Harada, S. Okazaki, Y. Iizuka, et al. (2008)
J. Lipid Res. 49, 1829-1838
   Abstract »    Full Text »    PDF »
Targeted Depletion of Hepatic ACAT2-driven Cholesterol Esterification Reveals a Non-biliary Route for Fecal Neutral Sterol Loss.
J. M. Brown, T. A. Bell III, H. M. Alger, J. K. Sawyer, T. L. Smith, K. Kelley, R. Shah, M. D. Wilson, M. A. Davis, R. G. Lee, et al. (2008)
J. Biol. Chem. 283, 10522-10534
   Abstract »    Full Text »    PDF »
Genetics of Cardiovascular Diseases: From Single Mutations to the Whole Genome.
F. Cambien and L. Tiret (2007)
Circulation 116, 1714-1724
   Full Text »    PDF »
Systematic Mutagenesis of Potential Glycosylation Sites of Lysosomal Acid Lipase.
O. Zschenker, C. Bahr, U.-F. Hess, and D. Ameis (2005)
J. Biochem. 137, 387-394
   Abstract »    Full Text »    PDF »
Transendothelial exchange of low-density lipoprotein is unaffected by the presence of severe atherosclerosis.
K. Kornerup, B. G. Nordestgaard, T. K. Jensen, B. Feldt-Rasmussen, J. P. Eiberg, K. S. Jensen, and J. S. Jensen (2004)
Cardiovasc Res 64, 337-345
   Abstract »    Full Text »    PDF »
Endothelial Lipase Promotes the Catabolism of ApoB-Containing Lipoproteins.
U. C. Broedl, C. Maugeais, J. S. Millar, W. Jin, R. E. Moore, I. V. Fuki, D. Marchadier, J. M. Glick, and D. J. Rader (2004)
Circ. Res. 94, 1554-1561
   Abstract »    Full Text »    PDF »
Hepatic Steatosis: A Mediator of the Metabolic Syndrome. Lessons From Animal Models.
M. den Boer, P.J. Voshol, F. Kuipers, L.M. Havekes, and J.A. Romijn (2004)
Arterioscler. Thromb. Vasc. Biol. 24, 644-649
   Abstract »    Full Text »    PDF »
Apolipoprotein E isoforms, serum cholesterol, and cancer.
M. B Katan (2004)
Int. J. Epidemiol. 33, 9
   Full Text »    PDF »
Cholesteryl ester transfer protein expression attenuates atherosclerosis in ovariectomized mice.
P. M. Cazita, J. A. Berti, C. Aoki, M. Gidlund, L. M. Harada, V. S. Nunes, E. C. R. Quintao, and H. C. F. Oliveira (2003)
J. Lipid Res. 44, 33-40
   Abstract »    Full Text »    PDF »
Transvascular Low-Density Lipoprotein Transport in Patients With Diabetes Mellitus (Type 2): A Noninvasive In Vivo Isotope Technique.
K. Kornerup, B. G. Nordestgaard, B. Feldt-Rasmussen, K. Borch-Johnsen, K. S. Jensen, and J. S. Jensen (2002)
Arterioscler. Thromb. Vasc. Biol. 22, 1168-1174
   Abstract »    Full Text »    PDF »
Prevention of Coronary Heart Disease by Diet and Lifestyle: Evidence From Prospective Cross-Cultural, Cohort, and Intervention Studies.
D. Kromhout, A. Menotti, H. Kesteloot, and S. Sans (2002)
Circulation 105, 893-898
   Full Text »    PDF »
Characterization of lysosomal acid lipase mutations in the signal peptide and mature polypeptide region causing Wolman disease.
O. Zschenker, N. Jung, J. Rethmeier, S. Trautwein, S. Hertel, M. Zeigler, and D. Ameis (2001)
J. Lipid Res. 42, 1033-1040
   Abstract »    Full Text »    PDF »
Rapid initial removal of chylomicron remnants by the mouse liver does not require hepatically localized apolipoprotein E.
K. C-W. Yu, Y. Jiang, W. Chen, and A. D. Cooper (2000)
J. Lipid Res. 41, 1715-1727
   Abstract »    Full Text »
Lipoprotein Lipase (LPL) Strongly Links Native and Oxidized Low Density Lipoprotein Particles to Decorin-coated Collagen. ROLES FOR BOTH DIMERIC AND MONOMERIC FORMS OF LPL.
M. O. Pentikainen, K. Oorni, and P. T. Kovanen (2000)
J. Biol. Chem. 275, 5694-5701
   Abstract »    Full Text »    PDF »
Cholesterol and Lipoprotein Metabolism in Aging : Reversal of Hypercholesterolemia by Growth Hormone Treatment in Old Rats.
P. Parini, B. Angelin, and M. Rudling (1999)
Arterioscler. Thromb. Vasc. Biol. 19, 832-839
   Abstract »    Full Text »    PDF »
Human mycoses: drugs and targets for emerging pathogens.
N. Georgopapadakou and T. Walsh (1994)
Science 264, 371-373
   PDF »
Transfer of Apolipoproteins between Plasma Lipoproteins and Exogenous Lipid Particles after Repeated Bolus Injections or during a Continuous Infusion of Fat Emulsion.
H. Tonouchi, K. Iriyama, and Y. A. Carpentier (1990)
JPEN J Parenter Enteral Nutr 14, 381-385
   Abstract »    PDF »
Cellular and Molecular Biology of Lipoprotein Metabolism: Characterization of Lipoprotein Receptor-Ligand Interactions.
R.W. Mahley, T.L. Innerarity, K.H. Weisgraber, S.C. Rall Jr., D.Y. Hui, A. Lalazar, J.K. Boyles, J.M. Taylor, and B. Levy-Wilson (1986)
Cold Spring Harb Symp Quant Biol 51, 821-828
   Abstract »    PDF »
Distinct hepatic receptors for low density lipoprotein and apolipoprotein E in humans.
J. Hoeg, S. Demosky Jr, R. Gregg, E. Schaefer, and H. Brewer Jr (1985)
Science 227, 759-761
   Abstract »    PDF »
Mevinolin Plus Colestipol in Therapy for Severe Heterozygous Familial Hypercholesterolemia.
D. R. ILLINGWORTH (1984)
Ann Intern Med 101, 598-604
   Abstract »    PDF »
Influence of Gemfibrozil and Clofibrate on Metabolism of Cholesterol and Plasma Triglycerides in Man.
Y. A. Kesaniemi and S. M. Grundy (1984)
JAMA 251, 2241-2246
   Abstract »    PDF »
Type III Hyperlipoproteinemia: Diagnosis, Molecular Defects, Pathology, and Treatment.
H. B. BREWER Jr., L. A. ZECH, R. E. GREGG, D. SCHWARTZ, and E. J. SCHAEFER (1983)
Ann Intern Med 98, 623-640
   Abstract »    PDF »
Independent pathways for secretion of cholesterol and apolipoprotein E by macrophages.
S. Basu, J. Goldstein, and M. Brown (1983)
Science 219, 871-873
   Abstract »    PDF »
The Mechanism of Action of Lipid-Lowering Drugs.
J. C. LaRosa (1982)
Angiology 33, 562-576
   PDF »
Endocrinology and Metabolism: An Annotated Bibliography of Recent Literature: References to Journal Articles and Other Papers.
ENDOCRINOLOGY AND METABOLISM COMMITTEE, MEDICAL KNOWLEDGE SELF-ASSESSMENT PROGRAM VI, and AMERICAN COLLEGE OF PHYSICIANS (1982)
Ann Intern Med 97, 151-157
   Abstract »    PDF »
Atherosclerosis: Prevention by agents not affecting abnormal levels of blood lipids.
D. Kramsch, A. Aspen, and L. Rozler (1981)
Science 213, 1511-1512
   PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)